|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
87,300,000 |
Market
Cap: |
18.04(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.2066 - $0.2066 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Agile Therapeutics is a women's healthcare company. Co.'s primary product candidate, Twirla, is a once-weekly prescription combination hormonal contraceptive patch. It delivers a dose of estrogen that is consistent with commonly prescribed combined hormonal contraceptives. Co.'s pipeline consists of two classes of product candidates: Co.'s potential product pipeline consists of two types of product candidates: a progestin-only contraceptive patch and potential Twirla line extensions. These potential product candidates are designed to address market needs and provide additional non-daily contraceptive options. Including AG200-15 Extended Regimen, AG200-SmP, and AG200-15 ER SmP.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gilmore Geoffrey |
General Counsel |
|
2019-01-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,480 |
28,212 |
|
- |
|
Conway Robert G |
SVP Ent Planning & Info Mgt |
|
2019-01-24 |
4 |
D |
$0.89 |
$2,083 |
D/D |
(2,350) |
6,275 |
|
- |
|
Conway Robert G |
SVP Ent Planning & Info Mgt |
|
2019-01-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,625 |
8,625 |
|
- |
|
Coiante Scott M |
Chief Financial Officer |
|
2019-01-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,070 |
30,756 |
|
- |
|
Edelman Joseph |
Former 10% Owner |
|
2018-07-26 |
4 |
S |
$0.30 |
$89,439 |
I/I |
(298,628) |
3,231,372 |
|
- |
|
Fischer Seth H.z. |
Director |
|
2018-06-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,949 |
17,949 |
|
- |
|
Tursi James Patrick |
Director |
|
2018-06-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,949 |
17,949 |
|
- |
|
Hubbard John W |
Director |
|
2018-06-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,949 |
17,949 |
|
- |
|
Lele Abhijeet J |
Director |
|
2018-06-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,949 |
17,949 |
|
- |
|
Shetty Ajit |
Director |
|
2018-06-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,949 |
24,949 |
|
- |
|
Mckee William |
Director |
|
2018-06-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,949 |
17,949 |
|
- |
|
Altomari Alfred |
Chief Executive Officer |
|
2018-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,667 |
178,254 |
|
- |
|
Gilmore Geoffrey |
General Counsel |
|
2018-01-25 |
4 |
D |
$3.32 |
$19,150 |
D/D |
(5,768) |
11,732 |
|
- |
|
Gilmore Geoffrey |
General Counsel |
|
2018-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
17,500 |
|
- |
|
Selman Renee |
Chief Commercial Officer |
|
2018-01-25 |
4 |
D |
$3.32 |
$21,431 |
D/D |
(6,455) |
71,628 |
|
- |
|
Selman Renee |
Chief Commercial Officer |
|
2018-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
78,083 |
|
- |
|
Garner Elizabeth |
Sr. VP & Chief Medical Officer |
|
2018-01-25 |
4 |
D |
$3.32 |
$19,140 |
D/D |
(5,765) |
11,735 |
|
- |
|
Garner Elizabeth |
Sr. VP & Chief Medical Officer |
|
2018-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
17,500 |
|
- |
|
Coiante Scott M |
Chief Financial Officer |
|
2018-01-25 |
4 |
D |
$3.32 |
$22,420 |
D/D |
(6,753) |
14,686 |
|
- |
|
Coiante Scott M |
Chief Financial Officer |
|
2018-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
21,439 |
|
- |
|
Conway Robert G |
SVP Chief Supply Chain Officer |
|
2017-10-03 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
6,200 |
|
- |
|
Selman Renee |
Chief Commercial Officer |
|
2017-08-25 |
4 |
B |
$3.35 |
$24,288 |
D/D |
7,250 |
60,583 |
2.74 |
- |
|
Altomari Alfred |
Chairman & Chief Executive Off |
|
2017-08-25 |
4 |
B |
$3.34 |
$33,400 |
D/D |
10,000 |
161,587 |
2.81 |
- |
|
Shetty Ajit |
Director |
|
2017-06-12 |
4 |
OE |
$3.75 |
$26,250 |
D/D |
7,000 |
7,000 |
|
- |
|
Selman Renee |
Chief Commercial Officer |
|
2017-05-11 |
4 |
B |
$3.68 |
$196,265 |
D/D |
53,333 |
53,333 |
2.74 |
- |
|
116 Records found
|
|
Page 4 of 5 |
|
|